Navigation Links
The PLSG Invests $115,000 in Innovention Technologies, LLC
Date:10/24/2007

PITTSBURGH, Oct. 24 /PRNewswire/ -- The Pittsburgh Life Sciences Greenhouse (PLSG), the private/public partnership putting the region's life sciences industry on a fast track for growth, announced that the PLSG has invested $115,000 in Innovention Technologies, LLC, a developmental-stage medical device company, whose goal is to develop and commercialize a highly-maneuverable surgical probe that will alleviate the existing limitations of endoscopic devices used in minimally invasive surgery (MIS).

Innovention Technologies is a spin-out from Carnegie Mellon University and it is led by an interdisciplinary team of experts in robotics, robotic surgery and minimally-invasive cardiac surgery (MICS).

Innovention Technologies is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military and law enforcement. The company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path. Innoventions' first product is a highly-articulated robotic probe (HARP) with feeder (the "HARP Product"). The HARP Product is highly maneuverable and once entered through a natural orifice or small incision, is designed to steer around organs to reach anatomical targets not normally accessible by conventional endoscopic tools. The HARP mechanical features include its ability to alternate between being rigid and flexible, and "remember" its previous configurations. This allows the HARP to reach very small cavities within the body and remain in a desired shape and orientation while the doctor performs surgery without having to hold the device anymore.

"The PLSG is excited to support Innoventions' continued commercialization efforts. Innoventions' core technology promises to combine advanced, yet simple methodologies in robotic surgery to more effectively deliver intended surgical benefits for increased patient care," said John W. Manzetti, PLSG's President and CEO. Mr. Manzetti continued, "The experienced management team has combined MIS and an emerging robotics technology to strategically and competitively position Innoventions in a large medical device market."

About the Pittsburgh Life Sciences Greenhouse (PLSG)

The PLSG invests in and supports the growth of biosciences companies in southwestern Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the Greater Pittsburgh region. http://www.plsg.com

About Innovention Technologies, LLC

Innovention Technologies LLC is developing advanced robotic technologies for use in a wide range of applications, including: medical, industrial, military and law enforcement. The Company's highly articulated robotic probes have unlimited degrees of freedom, are teleoperated, and are able to steer a self-supported, non-linear path. Within the medical field, the Company plans to serve a number of different specialist areas, including: minimally-invasive cardiac surgery, electrophysiology, laparoscopy, colonoscopy and arthroscopy. http://www.innoventllc.com


'/>"/>
SOURCE Pittsburgh Life Sciences Greenhouse
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Milwaukee angel network invests in St. Louis company
2. Froedtert invests $1.5M in local medical imaging startup
3. GE Healthcare invests $37.5 million in Chinese bio-sciences manufacturing facility
4. Wisconsin Insurance Company Invests in DotCom Company
5. Madison business receives $115,000 of new state biofuels funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... (PRWEB) , ... December 02, ... ... (ETC), a consortium of pharmaceutical and biotechnology companies dedicated to collaboratively developing ... companies interested in supplying a vendor-supported, portable online UHPLC, with robust, probe-based ...
(Date:12/2/2016)... , December 2, 2016 The ... 2021, growing at a CAGR of 7.3% during the forecast period ... hospitals and diagnostic laboratories segment accounted for the largest share of ... ... report on global immunohistochemistry (IHC) market spread across 225 pages, profiling ...
(Date:11/30/2016)... 30, 2016  GenomOncology today announced the appointment of ... Affairs.  Dr. Coleman will oversee clinical content ... knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with ... and clinical decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... 2016 Biotest Pharmaceuticals Corporation (BPC), a leading ... the addition of its newest plasma collection center located ... . The 15,200 square foot state-of-the-art facility officially opened ... brings the total number of BPC,s plasma collection centers ... BPC,s Chief Executive Officer said "We are pleased to ...
Breaking Biology Technology:
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
Breaking Biology News(10 mins):